0001104659-20-033412.txt : 20200313 0001104659-20-033412.hdr.sgml : 20200313 20200313190447 ACCESSION NUMBER: 0001104659-20-033412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200312 FILED AS OF DATE: 20200313 DATE AS OF CHANGE: 20200313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rolph Timothy CENTRAL INDEX KEY: 0001779479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 20714710 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 170 HARBOR WAY, 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 170 HARBOR WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 170 HARBOR WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 a4.xml 4 X0306 4 2020-03-12 0 0001744659 Akero Therapeutics, Inc. AKRO 0001779479 Rolph Timothy C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY, 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific Officer Common Stock 2020-03-12 4 M 0 27368 0.61 A 220277 D Common Stock 2020-03-12 4 M 0 22656 0.61 A 242933 D Stock Option (Right to Buy) 0.61 2020-03-12 4 M 0 27368 0 D 2028-10-17 Common Stock 27368 94268 D Stock Option (Right to Buy) 0.61 2020-03-12 4 M 0 22656 0 D 2028-07-29 Common Stock 22656 42796 D Shares vested and became exercisable in equal monthly installments for a period of 48 months following October 1, 2018. 25% of this option vested on August 1, 2018 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter. /s/ Jonathan Young, Attorney-in-Fact 2020-03-13